Physician profile
Alfredo Dosdos
NPI 1427004548
$1,631.48
in general payments reported to CMS, 2019-2025
27 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $70.22 · 2021: $268 · 2022: $358 · 2023: $190 · 2024: $205 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $170.09 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $165.39 | 2019-2023 | |
| Astellas Pharma US INC | $151.43 | 2019-2022 | |
| Novo Nordisk INC | $143.07 | 2019-2025 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $127.11 | 2019-2022 | |
| Abbvie INC. | $121.72 | 2021-2024 | Vraylar, Ubrelvy, Qulipta |
| Janssen Pharmaceuticals, INC | $89.35 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $61.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $56.55 | 2022-2023 | |
| Daiichi Sankyo INC. | $52.85 | 2022 | |
| Sonex Health, INC. | $48.67 | 2025 | Sx-One Microknife |
| Glaxosmithkline, LLC. | $48.31 | 2022-2023 | Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $46.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $46.46 | 2023-2024 | Rexulti, Nuedexta |
| Astrazeneca Pharmaceuticals LP | $44.64 | 2024 | Airsupra |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $41.66 | 2022 | |
| Dexcom, INC. | $31.19 | 2024-2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $29.90 | 2019 | |
| Integra Lifesciences Corporation | $23.19 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Genentech USA, INC. | $22.51 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $19.80 | 2022 | |
| Lilly USA, LLC | $18.21 | 2019 | |
| Exact Sciences Corporation | $16.66 | 2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $15.83 | 2021 | |
| Intuitive Surgical, INC. | $13.79 | 2019 | |
| Currax Pharmaceuticals LLC | $13.27 | 2022 | |
| Smith+Nephew, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Dosdos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.